These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 7119442)

  • 1. Prophylactic immunization against experimental leishmaniasis: I. Protection induced in mice genetically vulnerable to fatal Leishmania tropica infection.
    Howard JG; Nicklin S; Hale C; Liew FY
    J Immunol; 1982 Nov; 129(5):2206-12. PubMed ID: 7119442
    [No Abstract]   [Full Text] [Related]  

  • 2. Prophylactic immunization against experimental leishmaniasis. III. Protection against fatal Leishmania tropica infection induced by irradiated promastigotes involves Lyt-1+2- T cells that do not mediate cutaneous DTH.
    Liew FY; Howard JG; Hale C
    J Immunol; 1984 Jan; 132(1):456-61. PubMed ID: 6228580
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prophylactic immunization against experimental leishmaniasis. II. Further characterization of the protective immunity against fatal Leishmania tropica infection induced by irradiated promastigotes.
    Howard JG; Liew FY; Hale C; Nicklin S
    J Immunol; 1984 Jan; 132(1):450-5. PubMed ID: 6197456
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distinctive cellular immunity in genetically susceptible BALB/c mice recovered from Leishmania major infection or after subcutaneous immunization with killed parasites.
    Liew FY; Dhaliwal JS
    J Immunol; 1987 Jun; 138(12):4450-6. PubMed ID: 3295049
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Independence of the delayed hypersensitivity response from protection against Leishmania mexicana pifanoi].
    Pérez HA; De la Rora M
    Acta Cient Venez; 1986; 37(5):542-6. PubMed ID: 2966535
    [No Abstract]   [Full Text] [Related]  

  • 6. Prophylactic immunization against experimental leishmaniasis. IV. Subcutaneous immunization prevents the induction of protective immunity against fatal Leishmania major infection.
    Liew FY; Hale C; Howard JG
    J Immunol; 1985 Sep; 135(3):2095-101. PubMed ID: 4020140
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanisms of acquired immunity in leishmaniasis.
    Howard JG; Liew FY
    Philos Trans R Soc Lond B Biol Sci; 1984 Nov; 307(1131):87-98. PubMed ID: 6151691
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional heterogeneity of CD4+ T cells in leishmaniasis.
    Liew FY
    Immunol Today; 1989 Feb; 10(2):40-5. PubMed ID: 2568842
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Experimental cutaneous leishmaniasis. V. Protective immunity in subclinical and self-healing infection in the mouse.
    Preston PM; Dumonde DC
    Clin Exp Immunol; 1976 Jan; 23(1):126-38. PubMed ID: 1261086
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Immunization of BALB/c mice with cultured amastigotes of Leishmania mexicana amazonensis: protection by gamma-irradiated parasites].
    Hu XS; Chang KP
    Sichuan Yi Xue Yuan Xue Bao; 1985 Mar; 16(1):1-5. PubMed ID: 4012583
    [No Abstract]   [Full Text] [Related]  

  • 11. Immunization with the cysteine proteinase Ldccys1 gene from Leishmania (Leishmania) chagasi and the recombinant Ldccys1 protein elicits protective immune responses in a murine model of visceral leishmaniasis.
    Ferreira JH; Gentil LG; Dias SS; Fedeli CE; Katz S; Barbiéri CL
    Vaccine; 2008 Jan; 26(5):677-85. PubMed ID: 18160187
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DNA based vaccination with a cocktail of plasmids encoding immunodominant Leishmania (Leishmania) major antigens confers full protection in BALB/c mice.
    Ahmed SB; Touihri L; Chtourou Y; Dellagi K; Bahloul C
    Vaccine; 2009 Jan; 27(1):99-106. PubMed ID: 18951941
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isotype profiles of Leishmania donovani-infected BALB/c mice: preferential stimulation of IgG2a/b by liposome-associated promastigote antigens.
    Afrin F; Ali N
    J Parasitol; 1998 Aug; 84(4):743-8. PubMed ID: 9714204
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Leishmania mexicana: immunology and histopathology in C3H mice.
    Grimaldi G; Moriearty PL; Hoff R
    Exp Parasitol; 1980 Aug; 50(1):45-56. PubMed ID: 7389857
    [No Abstract]   [Full Text] [Related]  

  • 15. Generalized infection and lack of delayed hypersensitivity in BALB/c mice infected with Leishmania tropica major.
    Nasseri M; Modabber FZ
    Infect Immun; 1979 Nov; 26(2):611-4. PubMed ID: 546790
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of BCG on experimental cutaneous leishmaniasis in mice.
    Weintraub J; Weinbaum FI
    J Immunol; 1977 Jun; 118(6):2288-90. PubMed ID: 864260
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complete protection against experimental visceral leishmaniasis with complete soluble antigen from attenuated Leishmania donovani promastigotes involves Th1-immunity and down-regulation of IL-10.
    Bhaumik SK; Naskar K; De T
    Eur J Immunol; 2009 Aug; 39(8):2146-60. PubMed ID: 19593771
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo protection against Leishmania mexicana mediated by monoclonal antibodies.
    Anderson S; David JR; McMahon-Pratt D
    J Immunol; 1983 Oct; 131(4):1616-8. PubMed ID: 6619540
    [No Abstract]   [Full Text] [Related]  

  • 19. Kinetics and histopathology of the ear thickness test for delayed hypersensitivity in murine leishmaniasis.
    Grimaldi Filho G; Moriearty PL
    Rev Inst Med Trop Sao Paulo; 1981; 23(3):127-32. PubMed ID: 7280478
    [No Abstract]   [Full Text] [Related]  

  • 20. Experimental cutaneous leishmaniasis: disseminated leishmaniasis in genetically susceptible and resistant mice.
    Scott PA; Farrell JP
    Am J Trop Med Hyg; 1982 Mar; 31(2):230-8. PubMed ID: 6462064
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.